drugset / Trial / NCT00002051
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Completed
Immunobiology Research Institute
Double-blindTreatment
Summary
Examine the ability of thymopentin (Timunox) to: Reduce the amount and/or frequency of virus isolation. Stimulate the immune system and alter the clinical findings in patients infected with HIV who do not yet have AIDS.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymopentin | Peptide | — | — |